Keith W. Marshall

Overview

Keith W. Marshall received an average of $2M in total compensation, including $288K in salary, at Prometheus Biosciences between 2020 and 2021. Keith Marshall also received an average of $2M at Conatus Pharmaceuticals between 2017 and 2018.

Source: SEC filings on April 1, 2022, April 30, 2019, and April 27, 2018.

Related executives

We found 12 more executives who work or worked at Prometheus Biosciences and Conatus Pharmaceuticals.

Susan Knudson

Conatus Pharmaceuticals

Chief Financial Officer

Steven Mento

Conatus Pharmaceuticals

Chief Executive Officer

Joyce Reyes

Conatus Pharmaceuticals

Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations

Mark McKenna

Prometheus Biosciences

Chief Executive Officer

Allison Luo

Prometheus Biosciences

Chief Medical Officer

Mark Stenhouse

Prometheus Biosciences

Chief Operating Officer

Richard Pascoe

Conatus Pharmaceuticals

Chief Executive Officer

Gail Naughton

Conatus Pharmaceuticals

Chief Scientific Officer

News

You may also like